NFIB criticizes Governor Carney’s support for paid leave insurance program

Maggie Hall Senior Media Manager – Central
Maggie Hall Senior Media Manager – Central - Official Website
0Comments

Governor John Carney delivered his annual State of the State address from Legislative Hall in Dover, where he expressed support for Senate Bill 1, a paid leave insurance program. Mike O’Halloran, state director for the National Federation of Independent Business (NFIB) in Delaware, responded to this announcement.

O’Halloran acknowledged Governor Carney’s efforts during the pandemic: “Governor Carney was right to highlight the $400 million his administration provided for struggling small businesses through various grant and loan programs during the pandemic.” However, he criticized the proposed paid leave program: “Unfortunately, his support for a costly state-run program paid for by a new payroll tax on small business owners and their employees will undermine his administration’s efforts to help Delaware’s job creators recover from this economic crisis.”

O’Halloran argued that Senate Bill 1 would introduce “a new fixed labor cost,” which he believes will hinder rather than help resolve Delaware’s labor shortage.

The NFIB has been representing small and independent business owners across America since its founding in 1943. It is a nonprofit and nonpartisan organization dedicated to advocating on behalf of small businesses both at the federal level and in all state capitals.



Related

John T. Dorsey Chief Judge at U.S. Bankruptcy Court for the District of Delaware

Judge John T. Dorsey remembered after passing following battle with cancer

Judge John T. Dorsey has passed away following a battle with cancer, according to an announcement from the U.S. Bankruptcy Court for the District of Delaware on Apr. 15. He served as Chief Judge from 2024-2025 and had a long career dedicated to public service.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA inspection: Which types of Delaware companies faced the most scrutiny in March?

The U.S. Food and Drug Administration (FDA) carried out inspections at two food and cosmetics companies in Delaware during March.

Benjamin D. Moncarz Chief Financial Officer - FDA

Device companies saw the fewest FDA inspections in Delaware in 2025

The U.S. Food and Drug Administration (FDA) carried out an inspection at a device manufacturer in Delaware in 2025.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from First State Times.